• arclein
a, MASL may also be useful to treat and prevent a variety of other cancers that express PDPN. Dr. Goldberg's group has collaborated with the Developmental Therapeutics Program at the National Cancer Institute of the NIH to find that MASL can effectively suppress the growth of lung, breast, prostate, colon, and brain cancer cells that are often resistant to current therapies.
Watch Streaming Broadcast Live:
LRN.fm
DLive
Live Chat Telegram
Share this page with your friends
on your favorite social network: